RNS Number : 9001O
Legal & General UCITS ETF PLC
04 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
03/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
137471044.57 |
11.682 |
| L&G UK Equity UCITS ETF |
03/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
11335501.79 |
9.446 |
| L&G Global Equity UCITS ETF |
03/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32755281.29 |
11.295 |
| L&G Japan Equity UCITS ETF |
03/06/2020 |
IE00BFXR5T61 |
10745000 |
USD |
113518639.29 |
10.565 |
| L&G Europe ex UK Equity UCITS ETF |
03/06/2020 |
IE00BFXR5V83 |
9260988 |
EUR |
99923107.18 |
10.790 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
03/06/2020 |
IE00BFXR5W90 |
4405639 |
USD |
45372366.56 |
10.299 |
| L&G Clean Water UCITS ETF |
03/06/2020 |
IE00BK5BC891 |
1450000 |
USD |
15515960.58 |
10.701 |
| L&G Artificial Intelligence UCITS ETF |
03/06/2020 |
IE00BK5BCD43 |
5500000 |
USD |
66603499.94 |
12.110 |
| L&G Healthcare Innovation UCITS ETF |
03/06/2020 |
IE00BK5BC677 |
2400000 |
USD |
29657298.24 |
12.357 |
| L&G Pharma Breakthrough UCITS ETF |
03/06/2020 |
IE00BF0H7608 |
2400000 |
USD |
28513229.19 |
11.881 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
03/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
94763592.48 |
10.300 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
03/06/2020 |
IE00BKLWY790 |
57400000 |
USD |
600653197.01 |
10.464 |
| L&G Battery Value-Chain UCITS ETF |
03/06/2020 |
IE00BF0M2Z96 |
11400000 |
USD |
105390926.43 |
9.245 |
| L&G Ecommerce Logistics UCITS ETF |
03/06/2020 |
IE00BF0M6N54 |
5100000 |
USD |
53354526.64 |
10.462 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
03/06/2020 |
IE00BMW3QX54 |
46430616 |
USD |
816369539.88 |
17.583 |
| L&G Cyber Security UCITS ETF |
03/06/2020 |
IE00BYPLS672 |
82586776 |
USD |
1535168332.79 |
18.589 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVZZGGVZFFGGZZ
